Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-muscle Myosin II
100%
Glioblastoma
100%
Small Molecule Inhibitors
42%
Medicinal Chemistry
42%
Neurotherapeutics
42%
Murine Model
28%
Glioblastoma Cells
28%
In Vivo Efficacy
28%
Glioblastoma Cell Line
14%
Initial Diagnosis
14%
Therapeutic Target
14%
Chemotherapy-only
14%
Properties Improvement
14%
Allosteric Inhibitor
14%
Unmet Needs
14%
Compound Optimization
14%
Efficacy Testing
14%
Radiation Chemotherapy
14%
Molecular Motor
14%
Proof of Concept Study
14%
2-blocks
14%
In Vitro Screening
14%
Recurrence Rate
14%
Brain Tumor
14%
Genetic Interventions
14%
Translational Potential
14%
Therapeutic Needs
14%
Fast-growing
14%
Radiation Therapy
14%
Brain Cancer
14%
Proposed Work
14%
Cell Death
14%
Tolerability
14%
Standard of Care
14%
Tumor Resection
14%
Glioblastoma Therapy
14%
Cytokinesis
14%
Blebbistatin
14%
Penetrant
14%
Small Molecules
14%
Cell Division
14%
Pharmacology, Toxicology and Pharmaceutical Science
Myosin II
100%
Glioblastoma
100%
Pharmaceutical Chemistry
27%
Lead Compound
9%
Intracranial Tumor
9%
Brain Cancer
9%
efficacy testing
9%
Murine
9%
Tolerability
9%
Drug Dependence
9%
Blebbistatin
9%
In Vitro Screening
9%
Neoplasm
9%
Recurrent Disease
9%
Chemotherapy Regimens
9%
Biochemistry, Genetics and Molecular Biology
Myosin
100%
Small Molecule
57%
Cell Division
14%
Cell Death
14%
Genetics
14%
Scale up
14%
Murine
14%